Felicia Ladin
Finanzdirektor/CFO bei CYANOTECH CORPORATION
Vermögen: 1 094 $ am 31.05.2024
Profil
Felicia Ladin is currently the CFO, Treasurer, VP-Finance & Administration at Cyanotech Corp.
Prior to this, she was the Treasurer & Director at Curia Massachusetts, Inc. and the CFO & SVP-Global Specialty Medicines at Teva Pharmaceuticals USA, Inc. She also served as the President & Chief Financial Officer at Teva Pharmaceutical Industries Ltd.
from 2008 to 2014 and as the Chief Financial Officer, Treasurer & Senior VP at Curia Global, Inc. from 2015 to 2018.
Ms. Ladin holds a graduate degree from Seton Hall University and an undergraduate degree from the University of Delaware.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CYANOTECH CORPORATION
0,05% | 08.04.2024 | 3 587 ( 0,05% ) | 1 094 $ | 31.05.2024 |
Aktive Positionen von Felicia Ladin
| Unternehmen | Position | Beginn |
|---|---|---|
| CYANOTECH CORPORATION | Finanzdirektor/CFO | 28.09.2020 |
Ehemalige bekannte Positionen von Felicia Ladin
| Unternehmen | Position | Ende |
|---|---|---|
| ALBANY MOLECULAR RESEARCH, INC. | Finanzdirektor/CFO | 04.03.2018 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Finanzdirektor/CFO | 01.01.2014 |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Finanzdirektor/CFO | - |
Curia Massachusetts, Inc.
 Curia Massachusetts, Inc. Chemicals: SpecialtyProcess Industries AMRI Burlington, Inc. manufactures and distributes hyaluronate oligosaccharides. The company was founded on Andrea Wagner October 4, 1999 and is headquartered in Burlington, MA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Felicia Ladin
| University of Delaware | Undergraduate Degree |
| Seton Hall University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| CYANOTECH CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Curia Global, Inc.
 Curia Global, Inc. BiotechnologyHealth Technology Curia Global, Inc. engages in drug research and development, and manufacturing. It offers drug delivery, drug development, analytical services, API development and manufacturing, and drug product solutions. The company was founded by Thomas E. D'Ambra on June 19, 1991 and is headquartered in Albany, NY. | Health Technology |
Curia Massachusetts, Inc.
Curia Massachusetts, Inc. Chemicals: SpecialtyProcess Industries AMRI Burlington, Inc. manufactures and distributes hyaluronate oligosaccharides. The company was founded on Andrea Wagner October 4, 1999 and is headquartered in Burlington, MA. | Process Industries |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
